SCIENTIFIC MEETING DAY 1

SESSION 1 - ORAL FREE PAPER PRESENTATION

Residents and students will present their interesting case reports and case series during this session. A prize will be given for the top presentation.

CUTANEOUS ERUPTIONS ASSOCIATED WITH NEMOLIZUMAB IN ASIAN PATIENTS WITH ATOPIC DERMATITIS: A CASE SERIES
PEH CHONG HAN¹, CHEONG KAH WAI², YEW YIK WENG²
1. Tan Tock Seng Hospital
2. National Skin Centre, Singapore 

AN UNUSUAL FIRST PRESENTATION OF HIV: TOXIC EPIDERMAL NECROLYSIS WITHOUT AN IDENTIFIABLE TRIGGER
CHUN HIAN JOHN YAP¹, WEI QIANG CHNG¹,  CASSANDRA T CHEONG¹, 
WOO CHIAO TAY¹XUAN,  QI KOH^1,2
1. Division of Dermatology, Department of Medicine, National University Hospital
2. Department of Integrated Medicine, Alexandra Hospital 

PYOGENIC GRANULOMA WITH SECONDARY INFECTION ARISING WITHIN A PORT-WINE STAIN: A RARE CASE REPORT
NAYLA VALINKA ALMIRA¹, YASMIN AZZAHRA ARIFIN¹, GRACE AURELIA AMIPUTRI HOSIE¹, NOERIANTI ALETHA LEVIA ZALVA RACHMA¹ , IRMADITA CITRASHANTY², NOVITA IFAMELA³
1. Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia
2. Department of Dermatology, Venereology, and Aesthetics, Faculty of Medicine, Universitas Airlangga, Indonesia / Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
3. Dermatology, Venereology, and Aesthetics Residency Program, Faculty of Medicine, Universitas Airlangga, Indonesia / Dr. Soetomo General Academic Hospital, Surabaya, Indonesia 

A DIAGNOSTIC ODYSSEY OF CONFLUENT AND RETICULATED PAPILLOMATOSIS
TIANA TI¹, ZEN CHIA LIM², WOOI CHIANG TAN²
1. Medical Unit, Balik Pulau Hospital, Penang, Malaysia.
2. Department of Dermatology, Penang General Hospital, Penang, Malaysia. 

NODULAR LYMPHOEDEMATOUS FIBROSIS IN ELEPHANTIASIS NOSTRAS VERRUCOSA: AN UNDER-RECOGNISED ENTITY WITH DISTINCTIVE CLINICOPATHOLOGICAL FEATURES
CHENEY JIANLIN WONG¹, SUZANNE WEI NA CHENG¹, JOEL HUA LIANG LIM¹, HUI YI CHIA¹, JOYCE SIONG-SEE LEE¹
1. National Skin Centre, Singapore

SESSION 2 - UPDATES IN CUTANEOUS AND SEXUALLY TRANSMITTED INFECTIONS

A focused update on the latest and current topics in skin infections and sexually transmitted diseases, including monkeypox.

PHARMA-SPONSORED SYMPOSIUM

SESSION 3 - BEYOND THE TRIALS: LEBRIKIZUMAB IN REAL-WORLD ASIAN ATOPIC DERMATITIS

This session explores the practical application of lebrikizumab—a high-affinity IL-13 inhibitor—in treating atopic dermatitis, featuring real-world clinical insights from the National Skin Centre, Singapore.

SESSION 4 - SYMPOSIUM ON MEDICAL DERMATOLOGY

A primer on the hottest topics in inpatient medical dermatology, immunodermatology, as well as drug eruptions.

OPENING ADDRESS AND LAUNCH CEREMONY

VERACALM

VeraCalm is the first product under DermaCare SG collection, a series of skin health products formulated with the unique disease management needs of dermatology patients and diverse needs of Singapore's population in mind.

ASIAN SKIN ATLAS (THIRD EDITION)

An updated reference color atlas of dermatology and venereology in Asian skin with over 1500 new and refreshed clinical pictures across 29 chapters, including a new chapter in Oncodermatology.

SESSION 5 - PLENARY LECTURE "UNRAVELLING TRANSCUTANEOUS SENSITISATION TO FOODS"

There is mounting evidence that most children become allergic to foods through the skin. This lecture will describe the links between skin barrier impairment, atopic dermatitis and the development of food allergy, drawing evidence from observational and intervention studies, both in humans and animal modes. Novel methods of food allergy prevention that target the skin barrier will also be discussed.

PHARMA-SPONSORED LUNCH SYMPOSIUM

SESSION 6 - GUIDING THE WAY TO UNMET NEEDS IN PAEDIATRIC ATOPIC DERMATITIS

This is a practical talk on how to approach severe paediatric atopic dermatitis, unresponsive to topical and phototherapy, discussing both conventional and advanced systemic agents, recommendations from international treatment guidelines and how a living network meta-analysis can assist in therapeutic decision making. The key messages will be illustrated through real case scenarios.

SESSION 7 - SYMPOSIUM ON TECH-BASED DERMATOLOGY

Providing the latest insights in research-innovation enterprise, artificial intelligence, skin imaging as well as pharmaceutical compounding.

PHARMA-SPONSORED SYMPOSIUM

SESSION 8 - Beyond the Surface: Local Real-World Insights into IL-31 as the New Standard for AD & PN

IL-31 is a key driver of itch in atopic dermatitis (AD) and prurigo nodularis (PN), with nemolizumab shifting treatment focus towards pruritus control. This session presents real-world experience from the National Skin Centre, Singapore, examining treatment outcomes, dosing considerations, and patterns of itch and lesion improvement in AD and PN.

A particular focus will be placed on cutaneous adverse events, including emerging associations with facial involvement, erythema-predominant disease, and greater disease extent. Proposed mechanisms, including IL-31 blockade-related Th2 cytokine rebalancing, will be discussed alongside findings from recent Japanese real-world studies.

The talk aims to provide practical guidance on patient selection, expectation-setting, and adverse event recognition to support the integration of nemolizumab into routine dermatology practice.

SESSION 9 - SYMPOSIUM ON SKIN CANCERS

A comprehensive overview on challenging cases of skin cancers and cutaneous lymphomas, skin toxicities from anti-cancer therapies and AI diagnostics.